首页> 美国卫生研究院文献>Acta Pharmaceutica Sinica. B >Regulation of immune-related diseases by multiple factors ofchromatin exosomes microparticles vaccines oxidative stress dormancy proteinquality control inflammation and microenvironment: a meeting report of 2017International Workshop of the Chinese Academy of Medical Sciences (CAMS) Initiative forInnovative Medicine on Tumor Immunology
【2h】

Regulation of immune-related diseases by multiple factors ofchromatin exosomes microparticles vaccines oxidative stress dormancy proteinquality control inflammation and microenvironment: a meeting report of 2017International Workshop of the Chinese Academy of Medical Sciences (CAMS) Initiative forInnovative Medicine on Tumor Immunology

机译:通过多种因素调节免疫相关疾病染色质外泌体微粒疫苗氧化应激休眠蛋白质质量控制炎症和微环境:2017年会议报告中国医学科学院(CAMS)倡议国际研讨会肿瘤免疫学创新医学

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Immune cells play key roles in cancer and chronic inflammatory disease. A better understanding of the mechanisms and risks will help develop novel target therapies. At the 2017 International Workshop of the Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative Medicine on Tumor Immunology held in Beijing, China, on May 12, 2017, a number of speakers reported new findings and ongoing studies on immune-related diseases such as cancer, fibrotic disease, diabetes, and others. A considerably insightful overview was provided on cancer immunity, tumor microenvironments, and new immunotherapy for cancer. In addition, chronic inflammatory diseases were discussed. These findings may offer new insights into targeted immunotherapy.
机译:免疫细胞在癌症和慢性炎性疾病中起关键作用。更好地了解其机制和风险将有助于开发新颖的靶标疗法。在2017年5月12日于中国北京举行的2017年中国医学科学院(CAMS)肿瘤免疫学创新医学国际研讨会上,许多演讲者报告了有关免疫相关疾病的新发现和正在进行的研究包括癌症,纤维化疾病,糖尿病等。提供了有关癌症免疫力,肿瘤微环境和癌症新免疫疗法的颇有见地的概述。此外,还讨论了慢性炎症性疾病。这些发现可能为靶向免疫治疗提供新的见解。

著录项

相似文献

  • 外文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号